Biochemistry and Biophysics Reports (Sep 2016)

Creation of mouse TNFR2-selective agonistic TNF mutants using a phage display technique

  • Daisuke Ando,
  • Daisuke Ando,
  • Daisuke Ando,
  • Masaki Inoue,
  • Masaki Inoue,
  • Masaki Inoue,
  • Haruhiko Kamada,
  • Haruhiko Kamada,
  • Haruhiko Kamada,
  • Shintaro Taki,
  • Shintaro Taki,
  • Takeshi Furuya,
  • Takeshi Furuya,
  • Yasuhiro Abe,
  • Kazuya Nagano,
  • Kazuya Nagano,
  • Kazuya Nagano,
  • Yasuo Tsutsumi,
  • Yasuo Tsutsumi,
  • Yasuo Tsutsumi,
  • Shin-ichi Tsunoda,
  • Shin-ichi Tsunoda,
  • Shin-ichi Tsunoda,
  • Shin-ichi Tsunoda,
  • Shin-ichi Tsunoda

Journal volume & issue
Vol. 7, no. 2
pp. 309 – 315

Abstract

Read online

Tumor necrosis factor-α (TNF), which is an immuno-modulatory cytokine, has been suggested to cause inflammatory responses as well as protection against tissue dysfunction by binding two types of TNF receptor (TNFR1/TNFR2). However, the physiological effects of TNFR2-specific activation remain unclear. We therefore aimed to generate a TNF mutant with full TNFR2-selective agonist activity as a functional analytical tool. In this study, we utilized a phage display technique to create mouse TNFR2 (mTNFR2)-selective TNF mutants that bind specifically to mTNFR2 and show full bioactivity compared with wild-type TNF. A new phage library displaying TNF mutants was created, in which nine amino acid residues at the predicted receptor-binding site were randomized. From this library, an agonistic TNF mutant exhibiting high binding selectivity and bioactivity to mTNFR2 was isolated. We propose that this TNF mutant would be a powerful tool with which to elucidate the functional roles of mTNFR2.•We generated a TNF mutant with full TNFR2-selective agonist activity.•This mutant was identified using a phage display technique.•This agonist exhibited high binding selectivity and bioactivity to mouse TNFR2.•This would be a powerful tool to elucidate the functional roles of mouse TNFR2.

Keywords